Brief: Tempest Therapeutics Announced 1-For-13 Reverse Stock Split
07/04/2025 13:58
April 7 (Reuters) - Tempest Therapeutics Inc TPST.O: TEMPEST THERAPEUTICS INC - ON APRIL 4, ANNOUNCED 1-FOR-13 REVERSE STOCK SPLIT - SEC FILING TEMPEST THERAPEUTICS INC - REVERSE STOCK SPLIT EFFECTIVE APRIL 8, 2025 - SEC FILING Source text: [ID:n0001193125-25-073987] Further company coverage: TPST.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tempest Therapeutics
See all newsBrief: Tempest Therapeutics - Justin Trojanowski To Resign As Principal Financial Officer And Principal Accounting Officer Effective Sept 1 - SEC Filing
Tempest Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tempest Therapeutics - Enters $50 Million Common Stock Purchase Agreement With Lincoln Park
Tempest Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Tempest Announces Development Collaboration With Senlang Biotechnology For TPST-4003, A CD7-Targeted Next-Generation In Vivo CAR-T